CNSP

CNS Pharmaceuticals

• TipRanks·6d ago

  Insider Move at CNS Pharmaceuticals Sparks Investor Buzz

• NASDAQ·08/18 17:57

  CNSP Q2 Loss Widens As $22.5M Financing Fuels Strategic Pipeline Pivot

• TipRanks·08/17 09:41

  CNS Pharmaceuticals reports Q2 EPS (37c) vs. ($6.42) last year

• Seeking Alpha·08/12 12:05

  CNS Pharmaceuticals GAAP EPS of -$0.37 misses by $0.13

• Benzinga·07/14 12:05

  12 Health Care Stocks Moving In Tuesday's Pre-Market Session

• TipRanks·07/02 11:58

  CNS Pharmaceuticals Announces Strategic Oncology-Neurology Realignment

• Benzinga·07/01 12:05

  12 Health Care Stocks Moving In Wednesday's Pre-Market Session

• Benzinga·05/26 12:06

  12 Health Care Stocks Moving In Tuesday's Pre-Market Session

• TipRanks·05/21 02:09

  Insider Boost: CNS Pharmaceuticals Director Quietly Ramps Up His Stake

• TipRanks·05/19 21:01

  CNS Pharmaceuticals files to sell 9.79M shares of common stock for holders

• TipRanks·05/15 13:26

  Maxim Group Sticks to Their Buy Rating for CNS Pharmaceuticals (CNSP)

• TipRanks·05/14 16:25

  CNS Pharmaceuticals reports Q1 EPS ($7.30) vs. ($18.93) last year

• TipRanks·05/14 16:22

  CNS Pharmaceuticals sees cash runway ‘beyond’ twelve months

• Benzinga·05/14 12:28

  CNS Pharmaceuticals Q1 EPS $(7.30) Misses $(5.37) Estimate

• Seeking Alpha·05/14 12:06

  CNS Pharmaceuticals reports Q1 results